BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 28.60
+0.05 (0.18%)
May 29, 2026, 1:30 PM CST
BioLASCO Taiwan Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 43.39 | 42.43 | 44.03 | 49.74 | 42.31 | 45.15 |
Depreciation & Amortization | 12.07 | 11.53 | 10.97 | 10.57 | 9.96 | 9.99 |
Loss (Gain) From Sale of Assets | 0 | - | - | - | - | - |
Asset Writedown & Restructuring Costs | -0.13 | -0.06 | - | - | - | - |
Loss (Gain) on Equity Investments | -0.26 | -0.81 | -1.72 | -8.72 | -4.68 | -2.72 |
Provision & Write-off of Bad Debts | -0.02 | 0.07 | -0.04 | 0.05 | - | 0.04 |
Other Operating Activities | -3.48 | -3.82 | -5.67 | 2.88 | - | 2.92 |
Change in Accounts Receivable | 2.44 | 7.55 | 5.51 | -18.37 | -1.41 | 19.28 |
Change in Inventory | -0.73 | 6.17 | -4.24 | -12.73 | -3.89 | 2.27 |
Change in Accounts Payable | 0.86 | -14.36 | 14.12 | -2.95 | 2.77 | 1.26 |
Change in Unearned Revenue | 2.17 | 5.07 | -6.12 | 3.82 | 1.3 | -0.71 |
Change in Other Net Operating Assets | -2.01 | -5.07 | 0.02 | 5.17 | -1.66 | -6.63 |
Operating Cash Flow | 54.32 | 48.71 | 56.86 | 29.46 | 44.69 | 70.84 |
Operating Cash Flow Growth | -6.44% | -14.34% | 93.02% | -34.08% | -36.92% | -3.66% |
Capital Expenditures | -22.57 | -21.65 | -55.83 | -1.63 | -3.81 | -4.23 |
Sale (Purchase) of Intangibles | - | - | -0.11 | - | -0.46 | -0.13 |
Investment in Securities | -0 | -0 | -42.56 | -6.75 | -22.3 | -12 |
Other Investing Activities | 1.08 | 1.33 | 0.89 | -0.45 | -2.16 | 3.19 |
Investing Cash Flow | -21.49 | -20.32 | -97.6 | -8.83 | -28.72 | -13.17 |
Long-Term Debt Issued | - | - | 56 | - | - | - |
Long-Term Debt Repaid | - | -16.09 | -9.15 | -7.74 | -7.65 | -6.74 |
Net Debt Issued (Repaid) | -17.41 | -16.09 | 46.85 | -7.74 | -7.65 | -6.74 |
Common Dividends Paid | -38.42 | -38.42 | -42.26 | -38.42 | -40.98 | -51.23 |
Other Financing Activities | 0.01 | 0.01 | - | - | - | - |
Financing Cash Flow | -55.82 | -54.5 | 4.59 | -46.16 | -48.63 | -57.97 |
Net Cash Flow | -22.99 | -26.11 | -36.15 | -25.53 | -32.67 | -0.3 |
Free Cash Flow | 31.75 | 27.06 | 1.04 | 27.83 | 40.88 | 66.62 |
Free Cash Flow Growth | - | 2511.97% | -96.28% | -31.92% | -38.64% | - |
Free Cash Flow Margin | 12.04% | 10.30% | 0.35% | 10.51% | 17.33% | 29.27% |
Free Cash Flow Per Share | - | 1.05 | 0.04 | 1.08 | 1.59 | 2.60 |
Cash Interest Paid | 1.95 | 1.95 | 1.76 | 1.3 | 1.09 | 0.88 |
Cash Income Tax Paid | 10.21 | 10.21 | 15.96 | 9.54 | 10.91 | 8.43 |
Levered Free Cash Flow | 20.93 | 27.73 | -7.41 | 16.43 | 32.98 | 55.9 |
Unlevered Free Cash Flow | 22.2 | 29 | -6.32 | 17.24 | 33.66 | 56.45 |
Change in Working Capital | 2.74 | -0.64 | 9.28 | -25.06 | -2.9 | 15.47 |